|
Index of reports
> Cases with Diarrhoea (127)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) where reactions include diarrhoea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 127 Next >>
Possible Herceptin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: female, weighing 69.6 kg (153.2 pounds)
Reactions: Vomiting, Metabolic Acidosis, Diarrhoea, Nausea, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer
Start date: 2012-06-18
End date: 2012-06-18
Pertuzumab
Indication: Breast Cancer
Start date: 2012-06-18
End date: 2012-06-18
Docetaxel
Indication: Breast Cancer
Start date: 2012-06-18
End date: 2012-06-18
Other drugs received by patient: Neulasta; Taxol
Possible Herceptin side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20
Patient:
Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: arm b
Administration route: Oral
Indication: Breast Cancer
Cyclophosphamide
Indication: Breast Cancer
Lapatinib
Dosage: arm c
Administration route: Oral
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Herceptin
Dosage: maintenance dose
Fluorouracil
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Possible Herceptin side effects in 73 year old male
Reported by a pharmacist from Japan on 2012-08-15
Patient: 73 year old male, weighing 62.0 kg (136.4 pounds)
Reactions: Pruritus, Respiratory Failure, Diarrhoea, Anaemia, Infusion Related Reaction
Drug(s) suspected as cause:
Herceptin
Dosage: 8mg/kg
Indication: Metastatic Gastric Cancer
Start date: 2012-07-04
End date: 2012-07-04
Xeloda
Administration route: Oral
Indication: Metastatic Gastric Cancer
Start date: 2012-07-04
End date: 2012-07-04
Other drugs received by patient: Lansoprazole; Ferrous Citrate; Maglax; Alloid G; Acetaminophen; Promac; Hochuekkito
Possible Herceptin side effects in female
Reported by a physician from United States on 2012-08-15
Patient: female, weighing 57.6 kg (126.7 pounds)
Reactions: Abdominal Pain, Diarrhoea, Disseminated Intravascular Coagulation, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: permanently discontinued
End date: 2012-05-25
Docetaxel
Dosage: permanently discontinued
End date: 2012-05-25
Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-25
Docetaxel
Dosage: permanently discontinued
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Carboplatin
Dosage: permanently discontinued
End date: 2012-05-25
Herceptin
Dosage: maintanance dose, temporarily interrupted
End date: 2012-05-04
Carboplatin
Dosage: temporarily discontinued
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Herceptin
Dosage: loading dose, permanently discontinued
Indication: Breast Cancer
Start date: 2012-04-13
Other drugs received by patient: Clindamycin; Lovaza; Tylenol; Zofran
Possible Herceptin side effects in
Reported by a physician from Taiwan, Province of China on 2012-08-14
Patient:
Reactions: Hypersensitivity, Vomiting, Nausea, Diarrhoea, Alopecia, Anaemia
Drug(s) suspected as cause:
Herceptin
Dosage: loading dose, over 90 min on day 1, 1st cycle
Indication: Breast Cancer
Herceptin
Dosage: for 30 min on days 8 and 15, 1st cycle
Docetaxel
Dosage: on day 1, 1st cycle
Indication: Breast Cancer
Cisplatin
Dosage: for 24hours 1st cycle
Indication: Breast Cancer
Other drugs received by patient: Dexamethasone
Possible Herceptin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: female, weighing 64.9 kg (142.8 pounds)
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Vomiting, Gastrointestinal Haemorrhage, Nausea, Hyponatraemia, Hypokalaemia, Haemoglobin Decreased, Diarrhoea, Dehydration, Hypocalcaemia, Neutrophil Count Decreased, Blood Creatinine Increased, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: 139 milligram
Start date: 2012-07-18
Abraxane
Dosage: 177 milligram
Start date: 2012-07-18
End date: 2012-07-25
Herceptin
Dosage: 139 milligram
Indication: Breast Cancer
Start date: 2012-06-13
Abraxane
Dosage: 80 microgram/sq. meter
Start date: 2012-08-01
Carboplatin
Dosage: 675 milligram
Indication: Breast Cancer
Start date: 2012-06-13
Carboplatin
Dosage: 675 milligram
Start date: 2012-07-18
Abraxane
Dosage: 177 milligram
Indication: Breast Cancer
Start date: 2012-06-13
Other drugs received by patient: Dexamethasone; Gabapentin; Ativan; Motrin; Ativan; Vicodin; Ativan; Ativan
Possible Herceptin side effects in 73 year old male
Reported by a pharmacist from Japan on 2012-08-13
Patient: 73 year old male, weighing 62.0 kg (136.4 pounds)
Reactions: Pruritus, Diarrhoea, Respiratory Failure, Anaemia, Infusion Related Reaction
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Indication: Metastatic Gastric Cancer
Start date: 2012-07-04
End date: 2012-07-04
Herceptin
Dosage: 8mg/kg
Indication: Metastatic Gastric Cancer
Start date: 2012-07-04
End date: 2012-07-04
Other drugs received by patient: Hochuekkito; Alloid G; Acetaminophen; Lansoprazole; Maglax; Promac; Ferrous Citrate
Possible Herceptin side effects in female
Reported by a physician from United Kingdom on 2012-08-07
Patient: female, weighing 93.7 kg (206.0 pounds)
Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae: 29 july 2011, last dose 546 mg
Docetaxel
Dosage: dose decreased, date of last dose prior to sae: 11/nov/2011
Indication: Breast Cancer
Docetaxel
Dosage: dose decreased,last dose on 29 july 2011, last dose taken 75 mg
Start date: 2011-07-29
End date: 2011-11-11
Herceptin
Dosage: dose held.
Indication: Breast Cancer
Possible Herceptin side effects in female
Reported by a physician from Germany on 2012-07-19
Patient: female
Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer
Herceptin
Indication: Breast Cancer
Xeloda
Indication: Breast Cancer
Possible Herceptin side effects in female
Reported by a physician from United States on 2012-07-19
Patient: female, weighing 57.9 kg (127.4 pounds)
Reactions: White Blood Cell Count Decreased, Diarrhoea, Otitis Externa, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: 120 milligram
Start date: 2012-06-05
Herceptin
Dosage: 120 milligram
Start date: 2012-06-12
Carboplatin
Dosage: 720 milligram
Indication: Breast Cancer
Start date: 2012-04-17
End date: 2012-06-26
Abraxane
Dosage: 128 milligram
Indication: Breast Cancer
Start date: 2012-04-17
End date: 2012-06-26
Abraxane
Dosage: 118 milligram
Herceptin
Dosage: 2 milligram
Start date: 2012-05-29
Other drugs received by patient: Ciprofloxacin; Zofran; Neurontin; Protonix; Colace; Lovenox; Neurontin; Neupogen; Ciprofloxacin; Atenolol; Zolpidem; Magnesium Sulfate; Imodium; K-TAB; Vicodin; Zosyn; Zofran; Vancomycin; Levaquin; Morphine Sulfate; Ciprofloxacin HCL; Augmentin '500'; Acyclovir
Possible Herceptin side effects in female
Reported by a physician from Spain on 2012-07-12
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Mucosal Inflammation, Diarrhoea, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Pertuzumab
Dosage: maintanance dose, last dose prior to sae:11/jun/2012
Herceptin
Dosage: maintanance dose, last dose prior to sae:11/jun/2012
Docetaxel
Dosage: last dose prior to sae:11/jun/2012
Indication: Breast Cancer
Start date: 2012-04-30
Blinded Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Other drugs received by patient: Insulin; Bromazepam; Acetaminophen; Venlafaxine; Enalapril Maleate; Omeprazole; Gliclazide; Gemfibrozil; Metformin HCL; Atorvastan
Possible Herceptin side effects in female
Reported by a physician from United States on 2012-07-10
Patient: female
Reactions: Tooth Loss, Weight Decreased, Primary Sequestrum, Abdominal Pain, Pruritus, Metastases To Liver, Osteomyelitis, Tooth Infection, Erythema, Pericardial Effusion, Cardiac Disorder, Asphyxia, Haemangioma of Liver, Ecchymosis, Hypoxia, Nail Disorder, Pathological Fracture, Fluid Retention, Pneumonia, Fistula, Cellulitis, Anaemia, Paraesthesia, Decreased Interest, Hepatic Cyst, Atelectasis, Exposed Bone in JAW, Pain, Hypokalaemia, Neuropathy Peripheral, Bone Loss, Chest Pain, Onychoclasis, Pleural Effusion, Depression, Injury, Thrombocytopenia, Lymphoedema, Metastases To Lung, Emphysema, Tooth Fracture, Dyspnoea, Dental Caries, Sensation of Heaviness, Rash, Hydropneumothorax, Bronchopleural Fistula, Osteonecrosis of JAW, Diarrhoea, Impaired Healing, Ejection Fraction Decreased, JAW Disorder, Sinus Tachycardia
Drug(s) suspected as cause:
Taxotere
Dosage: 58 mg, qw
Herceptin
Dosage: 162 mg, qw
End date: 2007-06-11
Zometa
Dosage: 4 mg, qmo
Indication: Hypercalcaemia of Malignancy
Start date: 2003-12-01
End date: 2007-02-01
Zometa
Indication: Breast Cancer
Zometa
Indication: Metastases To Bone
Other drugs received by patient: Procrit; Decadron; Zofran; Coreg; Aranesp; Femara; Faslodex; Klor-CON; Torsemide; Lisinopril; Cleocin Hydrochloride; Vicodin; Adriamycin PFS; Carboplatin
Possible Herceptin side effects in 42 year old female
Reported by a physician from Poland on 2012-07-05
Patient: 42 year old female
Reactions: Diarrhoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Disease Progression
Drug(s) suspected as cause:
Herceptin
Indication: Product Used FOR Unknown Indication
Start date: 2007-10-17
End date: 2008-10-08
Xeloda
Indication: Product Used FOR Unknown Indication
Lapatinib
Indication: Product Used FOR Unknown Indication
Possible Herceptin side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-04
Patient: female
Reactions: Abdominal Pain, Weight Decreased, Tooth Loss, Primary Sequestrum, Pruritus, Metastases To Liver, Osteomyelitis, Tooth Infection, Erythema, Cardiac Disorder, Asphyxia, Pericardial Effusion, Haemangioma of Liver, Ecchymosis, Nail Disorder, Hypoxia, Pathological Fracture, Fluid Retention, Pneumonia, Cellulitis, Fistula, Anaemia, Decreased Interest, Paraesthesia, Atelectasis, Exposed Bone in JAW, Pain, Bone Loss, Neuropathy Peripheral, Chest Pain, Onychoclasis, Pleural Effusion, Depression, Injury, Thrombocytopenia, Metastases To Lung, Emphysema, Dyspnoea, Tooth Fracture, Dental Caries, Sensation of Heaviness, Rash, Hydropneumothorax, Bronchopleural Fistula, Diarrhoea, Osteonecrosis of JAW, Impaired Healing, Ejection Fraction Decreased, JAW Disorder, Sinus Tachycardia
Drug(s) suspected as cause:
Zometa
Dosage: 4 mg, qmo
Indication: Hypercalcaemia of Malignancy
Start date: 2003-12-01
End date: 2007-02-01
Zometa
Indication: Breast Cancer
Herceptin
Dosage: 162 mg, qw
End date: 2007-06-11
Taxotere
Dosage: 58 mg, qw
Zometa
Indication: Metastases To Bone
Other drugs received by patient: Lisinopril; Torsemide; Decadron; Femara; Zofran; Coreg; Aranesp; Cleocin Hydrochloride; Klor-CON; Procrit; Faslodex; Adriamycin PFS; Carboplatin; Vicodin
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Spain on 2012-07-02
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Mucosal Inflammation, Diarrhoea, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Pertuzumab
Dosage: maintanance dose, last dose prior to sae:11/jun/2012
Blinded Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Herceptin
Dosage: maintanance dose, last dose prior to sae:11/jun/2012
Docetaxel
Dosage: last dose prior to sae:11/jun/2012
Indication: Breast Cancer
Start date: 2012-04-30
Other drugs received by patient: Paracetamol; Omeprazole; Enalapril Maleate; Gemfibrozil; Insulin; Atorvastan; Bromazepam; Metformin HCL; Gliclazide; Loperamide; Venlafaxine
Possible Herceptin side effects in 77 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-22
Patient: 77 year old female
Reactions: Neutropenic Colitis, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-14
Cisplatin
Indication: Breast Cancer
Start date: 2012-02-08
Cisplatin
Indication: Gastric Cancer
Start date: 2012-02-08
Cisplatin
Start date: 2012-02-29
Herceptin
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-29
Cisplatin
Start date: 2012-02-29
Emend
Administration route: Oral
Start date: 2012-02-08
End date: 2012-03-02
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-02-08
End date: 2012-02-22
Emend
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-02-08
End date: 2012-03-02
Xeloda
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-22
Xeloda
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-14
Herceptin
Indication: Breast Cancer
Start date: 2012-02-08
End date: 2012-02-29
Other drugs received by patient: Iperten; Allopurinol; Xenetix; Lovenox; Magnesium Sulfate; Cordarone; Bisoprolol Fumarate and Hydrochlorothiazide; Lorazepam; Potassium Chloride; Nexium; Acetaminophen; Tramadol HCL; Zofran
Possible Herceptin side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-19
Patient:
Reactions: Thrombosis, Headache, Device Related Infection, Peripheral Sensory Neuropathy, Pericardial Effusion, Malaise, Dyspepsia, Granulocytopenia, Hypoxia, Pneumonitis, Blood Alkaline Phosphatase Increased, Hypotension, Anaemia, Hyperglycaemia, Dehydration, Neutropenia, Pain, Bone Pain, Hypokalaemia, Neutropenic Infection, Postoperative Wound Infection, Fatigue, Chest Pain, Depression, Lethargy, Vomiting, Dyspnoea, Lymphopenia, Alanine Aminotransferase Increased, Muscular Weakness, Febrile Neutropenia, Hypophosphataemia, Syncope, Arthralgia, Diarrhoea, Ejection Fraction Decreased, Hypermagnesaemia, Respiratory Tract Infection, Leukopenia, Infection
Drug(s) suspected as cause:
Vinorelbine Tartrate
Dosage: on day 8 and 15 of the 21 days cycle
Indication: Breast Cancer Metastatic
Herceptin
Docetaxel
Indication: Breast Cancer Metastatic
Herceptin
Indication: Breast Cancer Metastatic
Possible Herceptin side effects in 77 year old female
Reported by a physician from France on 2012-06-15
Patient: 77 year old female
Reactions: Neutropenic Colitis, Diarrhoea, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Start date: 2012-02-29
Xeloda
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-22
Xeloda
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-14
Herceptin
Start date: 2012-02-29
Emend
Dosage: on day 1, 2 and 3 of 14 day cycle
Indication: Vomiting
Start date: 2012-02-08
End date: 2012-03-02
Herceptin
Indication: Gastric Cancer
Start date: 2012-02-08
End date: 2012-02-29
Cisplatin
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-08
End date: 2012-02-29
Other drugs received by patient: Iperten; Nexium; Allopurinol; Xenetix; Bisoprolol Fumarate and Hydrochlorothiazide; Lovenox; Kaleorid LP; Zofran; Lorazepam; Acetaminophen; Tramadol HCL; Cordarone
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-13
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Vomiting, Diarrhoea, Ileus, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: most recent dose: 17/may/2012, last dose: 282mg
Indication: Gastric Cancer
Start date: 2012-03-29
Cisplatin
Dosage: dose reduced
Pertuzumab
Dosage: date of most recent dose of prior to ae:17/may/2012, last dose: 420mg
Indication: Gastric Cancer
Start date: 2012-03-29
Cisplatin
Dosage: last dose prior to ae onset: 17/may/2012, last dose: 60mg/m2
Indication: Gastric Cancer
Start date: 2012-03-29
Xeloda
Dosage: on 31 may 2012, the patient received last dose prior to adverse event, last dose taken: 750 mg/m2
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-03-29
Other drugs received by patient: Clarithromycin
Possible Herceptin side effects in female
Reported by a physician from Korea, Republic of on 2012-06-11
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Vomiting, Viral Infection, Ileus, Diarrhoea, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pertuzumab
Dosage: date of most recent dose of prior to ae:17/may/2012, last dose: 420mg
Indication: Gastric Cancer
Start date: 2012-03-29
Xeloda
Dosage: on 31 may 2012, the patient received last dose prior to adverse event, last dose taken: 750 mg/m2
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-03-29
Cisplatin
Dosage: last dose prior to ae onset: 17/may/2012, last dose: 60mg/m2
Indication: Gastric Cancer
Start date: 2012-03-29
Herceptin
Dosage: most recent dose: 17/may/2012, last dose: 282mg
Indication: Gastric Cancer
Start date: 2012-03-29
Other drugs received by patient: Clarithromycin
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from United Kingdom on 2012-06-08
Patient: female, weighing 93.0 kg (204.6 pounds)
Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae: 29 july 2011, last dose 546 mg
Docetaxel
Dosage: dose decreased,last dose on 29 july 2011, last dose taken 75 mg
Start date: 2011-07-29
End date: 2011-11-11
Docetaxel
Dosage: dose decreased,
Indication: Breast Cancer
Herceptin
Dosage: dose held.
Indication: Breast Cancer
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-06-08
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Vomiting, Ileus, Diarrhoea, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pertuzumab
Dosage: date of most recent dose of prior to ae:17/may/2012, last dose: 420mg
Indication: Gastric Cancer
Start date: 2012-03-29
Xeloda
Dosage: date of most recent dose of prior to ae: 17/may/2012, last dose taken: 750 mg/m2
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-03-29
Cisplatin
Dosage: last dose prior to ae onset: 17/may/2012, last dose: 60mg/m2
Indication: Gastric Cancer
Start date: 2012-03-29
Herceptin
Dosage: most recent dose: 17/may/2012, last dose: 282mg
Indication: Gastric Cancer
Start date: 2012-03-29
Possible Herceptin side effects in
Reported by a individual with unspecified qualification from Italy on 2012-06-05
Patient:
Reactions: Vomiting, Nausea, Anaemia, Palmar-Plantar Erythrodysaesthesia Syndrome, Diarrhoea, Neutropenia, Asthenia, Leukopenia, Deep Vein Thrombosis
Drug(s) suspected as cause:
Herceptin
Dosage: loading dose on day 1 of each cycle
Indication: Breast Cancer
Pegylated Liposomal Doxorubicin
Dosage: on day 1
Indication: Breast Cancer
Fluorouracil
Dosage: 200 mg/m2 as a continuous infusion from day 1 through day 21 to be repeated every 21 days for 8 cour
Indication: Breast Cancer
Herceptin
Dosage: on day 2 of each cycle
Cisplatin
Dosage: on day 1
Indication: Breast Cancer
Possible Herceptin side effects in 60 year old female
Reported by a individual with unspecified qualification from United States on 2012-06-01
Patient: 60 year old female, weighing 79.7 kg (175.3 pounds)
Reactions: Fatigue, Diarrhoea, Dehydration, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Tarceva
Administration route: Oral
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Herceptin
Indication: Breast Cancer
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-31
Patient: female, weighing 57.6 kg (126.7 pounds)
Reactions: Diarrhoea, Disseminated Intravascular Coagulation, Sepsis, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Docetaxel
Dosage: temporarily interrupted
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Herceptin
Dosage: loading dose, temporarily interrupted
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Carboplatin
Indication: Breast Cancer
Start date: 2012-04-13
Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-13
Other drugs received by patient: Zofran; Lovaza; Tylenol; Clindamycin
Possible Herceptin side effects in female
Reported by a physician from United States on 2012-05-31
Patient: female
Reactions: Diarrhoea, Dehydration, Hypotension, Vision Blurred, Hypoxia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: over 90 min on day 1, week 1 only
Indication: Breast Cancer
Start date: 2005-08-17
Carboplatin
Dosage: auc 2,over 1 hour on days 1,8 and 15.
Indication: Breast Cancer
Start date: 2005-08-17
Metoprolol Succinate
Indication: Product Used FOR Unknown Indication
Lorazepam
Indication: Product Used FOR Unknown Indication
Herceptin
Dosage: over 90 min on day 1,maintenance therapy
Epothilone NOS
Dosage: over 1 hour on days 1,8 and 15
Indication: Breast Cancer
Start date: 2005-08-17
Amlodipine
Indication: Product Used FOR Unknown Indication
Herceptin
Dosage: over 30 min on day1,8 ,15and 22 starting on week 2
Possible Herceptin side effects in female
Reported by a physician from United Kingdom on 2012-05-29
Patient: female, weighing 93.0 kg (204.6 pounds)
Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: dose held.
Indication: Breast Cancer
Docetaxel
Dosage: dose decreased,
Indication: Breast Cancer
Docetaxel
Dosage: dose decreased,last dose on 29 july 2011
Herceptin
Dosage: last dose prior to sae: 29 july 2011
Possible Herceptin side effects in 65 year old female
Reported by a consumer/non-health professional from United States on 2012-05-28
Patient: 65 year old female, weighing 81.7 kg (179.8 pounds)
Reactions: Oropharyngeal Pain, Dysgeusia, Weight Increased, Fatigue, Diarrhoea, Swelling, DRY Mouth, Ejection Fraction Decreased
Drug(s) suspected as cause:
Herceptin
Other drugs received by patient: Flagyl; Taxotere; Hydrochlorothiazide; Vancomycin
Possible Herceptin side effects in female
Reported by a physician from United Kingdom on 2012-05-28
Patient: female, weighing 93.0 kg (204.6 pounds)
Reactions: Diarrhoea, Neutropenic Sepsis, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: dose held.
Indication: Breast Cancer
Herceptin
Dosage: last dose prior to sae: 29 july 2011
Docetaxel
Dosage: dose decreased,last dose on 29 july 2011
Docetaxel
Dosage: dose decreased,
Indication: Breast Cancer
Possible Herceptin side effects in male
Reported by a physician from Canada on 2012-05-24
Patient: male
Reactions: Diarrhoea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Indication: Metastatic Gastric Cancer
Start date: 2011-10-31
Xeloda
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-01
End date: 2012-02-01
Cisplatin
Indication: Metastatic Gastric Cancer
Other drugs received by patient: Diovan
Page 1 Next >>
|
